CoChat

Effect of Lactobacillus paracasei CNCM I‐1572 on symptoms, gut microbiota, short chain fatty acids, and immune activation in patients with irritable bowel syndrome: A pilot randomized clinical trial

Open access
Cremon, Cesare, Guglielmetti, Simone, Gargari, Giorgio, Taverniti, Valentina, Castellazzi, Anna Maria, Valsecchi, Chiara, Tagliacarne, Carlotta, Fiore, Walter, Bellini, Massimo, Bertani, Lorenzo, Gambaccini, Dario, Cicala, Michele, Germanà, Bastianello, Vecchi, Maurizio, Pagano, Isabella, Barbaro, Maria Raffaella, Bellacosa, Lara, Stanghellini, Vincenzo, Barbara, Giovanni · 2018 · United European Gastroenterology Journal
Cited by 112

The DOI matches its Crossref record; 19 of the 19 references it cites were found in a registry or an index.

Abstract

Background: Evidence suggests a role of intestinal microbiota‐host interactions in the pathophysiology and symptoms of irritable bowel syndrome (IBS). Objective: The objective of this article is to assess the effects of Lactobacillus paracasei CNCM I‐1572 on clinical and gut microbiota‐related factors in IBS. Methods: We conducted a multicenter, randomized, double‐blind, cross‐over, 18‐week, placebo‐controlled, pilot trial assessing the effect of Lactobacillus paracasei CNCM I‐1572 on symptoms, gut microbiota composition, fecal short chain fatty acid (SCFA), immunoglobulin A, and cytokines in IBS. The intestinal microbial ecosystem was characterized by 16S rRNA gene profiling. Results: Forty IBS patients were enrolled from five Italian centers. Lactobacillus paracasei CNCM I‐1572 did not significantly improve IBS symptoms, including primary efficacy variables worst abdominal pain/discomfort and IBS degree of relief. Interestingly, Lactobacillus paracasei CNCM I‐1572 induced a significant reduction in genus Ruminococcus, dominated by taxa related to Ruminococcus bromii and Ruminococcus callidus, a significant increase in the SCFAs acetate and butyrate, and a significant reduction in the pro‐inflammatory cytokine interleukin‐15. Conclusions: This pilot study shows that Lactobacillus paracasei CNCM I‐1572 is able to modulate gut microbiota structure/function and reduce immune activation in IBS. As no statistically significant effect on IBS‐symptoms was found, further studies are necessary to determine the role of this probiotic in IBS. The study was registered at ClinicalTrials.gov registry under identifier NCT02371499.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1177/2050640617736478

Cites

19 of 19 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 19 references

Cited by

See all 112

Metadata

Authors
Cremon, C., Guglielmetti, S., Gargari, G., Taverniti, V., Castellazzi, A. M., Valsecchi, C., Tagliacarne, C., Fiore, W., Bellini, M., Bertani, L., Gambaccini, D., Cicala, M., Germanà, B., Vecchi, M., Pagano, I., Barbaro, M. R., Bellacosa, L., Stanghellini, V., & Barbara, G.
Venue
United European Gastroenterology Journal
Publisher
Wiley
Published
2018-05
Volume
6
Issue
4
Pages
604-613
ISSN
  • 2050-6406 (ISSN-L)
  • 2050-6414
OpenAlex
W2761380627
Cited by
112
References
19
FWCI
6.91
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Effect of Lactobacillus paracasei CNCM I‐1572 on symptoms, gut microbiota, short chain fatty acids, and immune activation in patients with irritable bowel syndrome: A pilot randomized clinical trial. https://app.cochat.ai/papers/10.1177/2050640617736478
The paper
Cremon, C., Guglielmetti, S., Gargari, G., Taverniti, V., Castellazzi, A. M., Valsecchi, C., Tagliacarne, C., Fiore, W., Bellini, M., Bertani, L., Gambaccini, D., Cicala, M., Germanà, B., Vecchi, M., Pagano, I., Barbaro, M. R., Bellacosa, L., Stanghellini, V., & Barbara, G. (2018). Effect of Lactobacillus paracasei CNCM I‐1572 on symptoms, gut microbiota, short chain fatty acids, and immune activation in patients with irritable bowel syndrome: A pilot randomized clinical trial. United European Gastroenterology Journal. https://doi.org/10.1177/2050640617736478

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.